Surrozen, Inc. Common
Symbol: SRZN (NASDAQ)
0.00
▼ (-100.00%) -13.650
Company Description:
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $13.65
- Yesterday High: $14.4
- Yesterday Low: $13.6
- Yesterday Volume: 11.81K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Surrozen, Inc. Common
- Website: https://www.surrozen.com
- Listed Date: 2021-08-12
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001824893
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $118.70M
- Round Lot: 100
- Outstanding Shares: 8.57M
- Asset Type: CS
RECENT FILINGS FOR SRZN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | 8-K | View |
| 2025-08-29 | 8-K | View |
| 2025-08-29 | 424B5 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-08 | S-8 | View |
| 2025-08-08 | 10-Q | View |
| 2025-08-08 | 8-K | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-05-23 | EFFECT | View |
| 2025-05-21 | CORRESP | View |
| 2025-05-21 | UPLOAD | View |
| 2025-05-20 | S-3 | View |
| 2025-05-15 | 4 | View |
| 2025-05-15 | 4 | View |
| 2025-05-15 | 4 | View |
Latest News on SRZN